Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GLYcoDiag is a French private biotechnology and applied glycomics company focused on glycobiology, glycoanalysis, glycomics, and microbiota-related R&D services and products. The company offers contract research, glycoanalytical services, lectin-based assays, and research reagents used in biomarker discovery, diagnostics, vaccine research, and characterization of therapeutic recombinant glycoproteins. Its commercial offering includes the GLYcoPROFILE platform and LEctPROFILE-branded kits and affinity products for studying glycan and glycan-binding protein interactions. Beyond health applications, the company also serves cosmetics and environmental research markets. Overall, GLYcoDiag appears to operate primarily as a specialized glycosciences tools-and-services company rather than a developer of a traditional therapeutic drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GLYcoDiag.